card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

TruSight Oncology 500 (TSO500) Tissue Assay

Home / Insights / TruSight Oncology 500 (TSO500) Tissue Assay

The TruSight Oncology 500 (TSO500) for tissue assay employs a hybrid capture-based approach targeting 523 genes and leverages unique molecular indices to enable detection of low allele frequency SNVs, insertions-deletions (indels), CNVs, gene fusions and splice variants. This comprehensive cancer panel interrogates relevant cancer biomarkers with as little as 40 ng of DNA and 40 ng of RNA isolated from FFPE tissue. Beyond these variant types, TSO500 determines tumor mutational burden (TMB) and microsatellite instability (MSI) scores. IQVIA Laboratories can meet your profiling needs by leveraging trusted technology from Illumina® and our expert support team in combination with Genomic Centers in the US, China, Edinburgh, and Singapore.


Download Document